Bacterin secures additional OrbiMed financing Bacterin International Holdings announced the closing of an additional $4M financing from OrbiMed. The additional $4M was provided on the same terms as the $20M term loan the company received in August of 2012. In conjunction with the financing, Bacterin agreed to issue 1.5 million shares of common stock to an affiliate of OrbiMed. The proceeds will be used by the company for working capital and general corporate purposes.
NYSE MKT to commence delisting proceedings against Bacterin NYSE MKT announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Bacterin International Holdings - ticker symbol BONE - from NYSE MKT.